EIF4G1 and melanoma: To exclude the possibility of a previously unidentified eIF4F-independent off-target effect of RocA on DUSP6 protein stability, we treated melanoma cells with 4E1RCat, a structurally unrelated compound inhibiting eIF4F by a different mechanism.